Muscular dystrophy is a genetic disorder that weakens muscles over time. There are many different types of muscular dystrophies. Each type begins at a different age and may cause mild or severe muscle ...

At the 44th Annual J.P. Morgan Healthcare Conference in early January 2026, Edgewise Therapeutics outlined its 2026 clinical ...

Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today provided updates on the Company's clinical programs and highlighted major milestones for 2026. Edgewise Chief ...

California-based Foresite Capital Management VI sold 585,000 shares of Edgewise Therapeutics in the third quarter. The overall position value fell by about $7.67 million from the previous period. The ...

An exceptionally brave, strong, and accomplished woman is now in God’s loving arms — Eileen Teresa O’Keefe Becker. She shared a marriage with her beloved husband, Timothy Becker. She was the daughter ...

This symposium took place on 8 th October 2025, as part of the 30 th Annual International Congress of the World Muscle Society (WMS) held in Vienna, Austria Dreghici is an employee of Edgewise ...

The U.S. Food and Drug Administration is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy after two teenagers died from liver failure linked to the medication. The ...

Introduction Duchenne and Becker muscular dystrophies (DMD and BMD) are devastating conditions characterised by progressive muscle degeneration and weakness. Despite advances in understanding their ...

What Is Becker Muscular Dystrophy? Becker muscular dystrophy (often called Becker MD or BMD) is a form of muscular dystrophy, a genetic disorder that gradually makes the body's muscles weaker and ...

"I don't like the attention at all," said Shep, as his family and friends call him, who gets a lot of it at school. "It just annoys me, that every day I'm asked, 'Hey, why do you need a wheelchair?' ...